Sirtuin 1 in Chronic Kidney Disease and Therapeutic Potential of Targeting Sirtuin 1
The incidence and prevalence of chronic kidney disease (CKD) continue to increase worldwide remaining as a major public health burden. CKD eventually progresses to end-stage kidney failure and patients with CKD have high morbidity and mortality. Sirtuin 1 (SIRT1), a NAD+-dependent deacetylases, has...
Main Authors: | Jiayi Yan, Jue Wang, John Cijiang He, Yifei Zhong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.917773/full |
Similar Items
-
Sirtuin Family and Diabetic Kidney Disease
by: Che Bian, et al.
Published: (2022-06-01) -
The Role of Sirtuins in Kidney Diseases
by: Yu Ah Hong, et al.
Published: (2020-09-01) -
Serum sirtuin 1 is independently associated with intact PTH among patients with chronic kidney disease
by: Bielach-Bazyluk A, et al.
Published: (2021-03-01) -
Comprehensive bibliometric analysis of sirtuins: Focus on sirt1 and kidney disease
by: Tongtong Liu, et al.
Published: (2022-08-01) -
Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease
by: Catarina Marreiros, et al.
Published: (2022-12-01)